Cosmo Pharmaceuticals N.V. (COPN.SW)

CHF 48.35

(1.47%)

Operating Expenses Summary of Cosmo Pharmaceuticals N.V.

  • Cosmo Pharmaceuticals N.V.'s latest annual operating expenses in 2023 was 47.29 Million EUR , up 20.82% from previous year.
  • Cosmo Pharmaceuticals N.V.'s latest quarterly operating expenses in 2024 Q1 was 12.64 Million EUR , down -13.69% from previous quarter.
  • Cosmo Pharmaceuticals N.V. reported a annual operating expenses of 55.27 Million EUR in annual operating expenses 2022, up 42.33% from previous year.
  • Cosmo Pharmaceuticals N.V. reported a annual operating expenses of 38.83 Million EUR in annual operating expenses 2021, down -10.93% from previous year.
  • Cosmo Pharmaceuticals N.V. reported a quarterly operating expenses of 12.64 Million EUR for 2024 Q1, down -13.69% from previous quarter.
  • Cosmo Pharmaceuticals N.V. reported a quarterly operating expenses of 9.07 Million EUR for 2023 Q1, down -3.88% from previous quarter.

Annual Operating Expenses Chart of Cosmo Pharmaceuticals N.V. (2023 - 2004)

Historical Annual Operating Expenses of Cosmo Pharmaceuticals N.V. (2023 - 2004)

Year Operating Expenses Operating Expenses Growth
2023 47.29 Million EUR 20.82%
2022 55.27 Million EUR 42.33%
2021 38.83 Million EUR -10.93%
2020 43.6 Million EUR -33.49%
2019 65.55 Million EUR -6.17%
2018 69.86 Million EUR 7.95%
2017 64.72 Million EUR 101.75%
2016 32.08 Million EUR -42.68%
2015 55.96 Million EUR 22.3%
2014 45.75 Million EUR 38.04%
2013 33.14 Million EUR 34.37%
2012 24.67 Million EUR 144.04%
2011 10.1 Million EUR -21.77%
2010 12.92 Million EUR 36.48%
2009 9.46 Million EUR -3.25%
2008 9.78 Million EUR -33.23%
2007 14.65 Million EUR 27.75%
2006 11.47 Million EUR 35.36%
2005 8.47 Million EUR 10.9%
2004 7.64 Million EUR 0.0%

Peer Operating Expenses Comparison of Cosmo Pharmaceuticals N.V.

Name Operating Expenses Operating Expenses Difference
Roche Holding AG 28.68 Billion CHF 99.835%
Roche Holding AG 28.68 Billion CHF 99.835%